Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$40.9 - $45.1 $1.27 Million - $1.4 Million
-30,935 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $1.18 Million - $1.39 Million
30,935 New
30,935 $1.31 Million
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $729,266 - $923,298
-21,999 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$34.44 - $42.23 $7.09 Million - $8.69 Million
-205,877 Reduced 90.35%
21,999 $841,000
Q2 2020

Aug 13, 2020

BUY
$30.19 - $39.11 $1.2 Million - $1.55 Million
39,658 Added 21.07%
227,876 $8 Million
Q1 2020

May 18, 2020

SELL
$25.83 - $45.71 $3.7 Million - $6.54 Million
-143,127 Reduced 43.2%
188,218 $6.14 Million
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $12.5 Million - $15 Million
331,345 New
331,345 $15 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Wexford Capital LP Portfolio

Follow Wexford Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Wexford Capital LP with notifications on news.